Angiotensins
Exforge HCT® the only 3-in-1 single pill high blood pressure therapy shown more effective than dual combinations of its components
Published in Hematology Week, July 27th, 2009
In a pivotal study published in Hypertension, Exforge HCT® (amlodipine, valsartan, hydrochlorothiazide) – recently approved by the US Food and Drug Administration (FDA) as the only three-in-one single pill for the treatment of high blood pressure – was shown to be more effective than the dual combination of its components in patients with moderate to severe hypertension (mean sitting systolic blood pressure [MSSBP] ≥ 145 mmHg and mean sitting diastolic blood pressure [MSDBP] ≥ 100 mmHg).
The study evaluated the maximum dose (10 mg/320 mg/25 mg) of Exforge HCT versus dual combinations of its components at the same doses. In addition, triple...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2009-07-27)
More Articles from Hematology Week
- American Association for Cancer Research
Circulating blood cells are important predictors of cancer spread in children - Lifespan
Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks - McGill University
Study reveals major genetic differences between blood and tissue cells - Abdominal Aortic Aneurysm
Society for Vascular Nursing Releases Patient Care Guideline: Published in June Issue of Journal of Vascular Nursing - AngioDynamics, Inc.
AngioDynamics Reports Fiscal Fourth Quarter and Full Year 2009 Financial Results - Angioplasty
Strategies for Lower Extremity Peripheral Artery Disease Compared - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
